<DOC>
	<DOC>NCT02447081</DOC>
	<brief_summary>This will be a prospective, multicenter, observational, non-randomized study to compile real world outcome data on the use of the Amulet™device in non-valvular atrial fibrillation (NVAF) subjects. The study is designed to follow the Instructions For Use (IFU) to gather data on the implant procedure through two years of follow up with the Amulet™ device in a commercial clinical setting.</brief_summary>
	<brief_title>Amplatzer™Amulet™ Post-Market Study</brief_title>
	<detailed_description>Approximately 1000 subjects will be enrolled in the study to reduce the impact of individual center bias, each site may enroll up to 50 subjects. The study will be conducted at up to 75 sites internationally, outside the United States. The study will be assessing acute and late serious adverse events and report on percentage of stroke and bleeding events through two years. No formal hypothesis will be tested for this observational post-market study. However, point estimates and exact 95% confidence intervals will be provided for the primary and secondary objectives. Each patient will be followed for a period of two years after enrollment. There will be no additional visits, nor procedures, for subjects who participate in the study. Subjects are expected to be followed at implant, 1-3 months post implant, 12 months and 24 months.</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<criteria>1. Subject with history of paroxysmal, persistent or permanent NVAF 2. Subject who is 18 years or older, or of legal age to give informed consent specific to state and national law 3. Subject who is eligible for an Amulet LAA Occluder device according to current international guidelines and per physician discretion 4. Subject who is willing and capable of providing informed consent, participating in all associated study activities 1. Subject with evidence of an intracardiac thrombus 2. Subject with active infection or active endocarditis or other infections producing bacteremia 3. Subject where the placement of the device would interfere with any intracardiac or intravascular structures 4. Subject with any medical disorder that would interfere with completion or evaluation of clinical study results 5. Women of childbearing potential who are, or plan to become, pregnant during the time of the study (method of assessment per physician discretion) 6. Subject with LAA anatomy that does not accommodate a device per the sizing guidelines</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>